Bioxyne Limited
Ticker
BXN.AX
ISIN
AU000000BXN
Price
-
Change Today
-
Price 1 year ago
-
Market Capitalization
17,283,916.00
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Bioxyne Limited, a life sciences and health products company, engages in the research and development, manufacture, and distribution of probiotic active pharmaceutical ingredients, wellbeing and nutritional supplements, and beauty products. The company operates in two segments, Wholesale Sales and Direct Sales. It engages in developing various functional foods and beauty products. The company's products portfolio includes Progastrim PCC, a proprietary probiotic, for general health and immune support; Mymana and ColosNZ, are colostrum and fortified milks for nutrition and immune support; BK18, a dairy based formula with probiotics and vitamins; Allura, a weight management and beauty drink for women; Mustang, a weight management and vitality shake for men; and BEssence, offers beauty range products comprising anti-ageing serum. Bioxyne Limited also offers foaming and toning cleanser, repair oils, and Progastrim, a probiotic dietary supplement for gut and immune health. The company provides its products online, as well as through wholesale and direct sales in Australia, the United States, New Zealand, and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Sector
Healthcare
Industry
Biotechnology
Country
Australia
Exchange
ASX
Earnings Per Share
-0.001
P/E Ratio
-
Debt/Equity Ratio
-
Beta
1.449928
Ebitda
162,174.00
Ebitda Margins
0.07
Enterprise to Ebitda
46.69
Enterprise Value
7,571,518.00
Target Price
-
Estimated Price
-
Book Value
0.00
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
Company | Name | Correlation |
---|---|---|
002007.SZ | HUALAN BIOLOGICAL | -0.556 |
DNA | Ginkgo Bioworks Holdings, Inc. | -0.517 |
300147.SZ | XIANGXUE PHARMACEU | -0.509 |
ATHX | Athersys, Inc. | -0.504 |
TMBR | Timber Pharmaceuticals, Inc. | -0.497 |
300122.SZ | CHONGQING ZHIFEI B | -0.467 |
600201.SS | JINYU BIO-TECHNOLOGY CO LTD | -0.403 |
1177.HK | SINO BIOPHARM | -0.396 |
BLUE | bluebird bio, Inc. | -0.345 |
0775.HK | CKLIFE SCIENCES | -0.314 |
1801.HK | INNOVENT BIO | -0.285 |
002252.SZ | S/H RAAS BLOOD PRO | -0.281 |
300363.SZ | PORTON PHARMA SOLU | -0.251 |
2269.HK | WUXI BIO | -0.127 |
1530.HK | 3SBIO | -0.105 |
300497.SZ | JIANGXI FUSHINE PH | -0.068 |
1873.HK | VIVA BIOTECH | -0.059 |
AKBA | Akebia Therapeutics, Inc. | -0.005 |
TRX.L | TISSUE REGENIX GROUP PLC | 0.023 |
ALPHA.PA | PHARNEXT | 0.024 |
300204.SZ | STAIDSON (BEIJING) | 0.056 |
300009.SZ | ANHUI ANKE BIOTECH | 0.175 |
2137.HK | BRII-B | 0.253 |
2370.T | MEDINET CO LTD | 0.326 |
600866.SS | STAR LAKE BIOSCIENCE CO INC Z | 0.358 |
600200.SS | JIANGSU WUZHONG PHARMACEUTICAL | 0.580 |
IMU.AX | IMUGENE FPO | 0.626 |
300181.SZ | ZHEJIANG JOLLY PHA | 0.687 |
Similar companies
Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
---|---|---|---|---|---|---|---|---|---|
ALPHA.PA | PHARNEXT | Issy-les-Moulineaux | France | EUR | PAR | 2.864 | -0.651 | 40 | https://www.pharnext.com |
1177.HK | SINO BIOPHARM | Wan Chai | Hong Kong | HKD | HKG | 0.478 | 17.584 | 25579 | https://www.sinobiopharm.com |
0775.HK | CKLIFE SCIENCES | Tai Po | Hong Kong | HKD | HKG | 0.404 | 32.464 | 1855 | https://www.ck-lifesciences.com |
DNA | Ginkgo Bioworks Holdings, Inc. | Boston | United States | USD | NYQ | -1.244 | 641 | https://www.ginkgobioworks.com | |
002252.SZ | S/H RAAS BLOOD PRO | Shanghai | China | CNY | SHZ | 0.211 | 19.620 | 2966 | https://www.raas-corp.com |
002007.SZ | HUALAN BIOLOGICAL | Xinxiang | China | CNY | SHZ | 0.028 | 19.245 | 2927 | https://www.hualanbio.com |
600200.SS | JIANGSU WUZHONG PHARMACEUTICAL | Suzhou | China | CNY | SHH | 0.563 | -710.433 | https://www.600200.com | |
600866.SS | STAR LAKE BIOSCIENCE CO INC Z | Zhaoqing | China | CNY | SHH | 0.350 | 21.346 | 2608 | https://www.starlake.com.cn |
TRX.L | TISSUE REGENIX GROUP PLC | Garforth | United Kingdom | GBp | LSE | 1.398 | -10.940 | 79 | https://www.tissueregenix.com |
2269.HK | WUXI BIO | Wuxi | China | HKD | HKG | 0.908 | 85.173 | 9864 | https://www.wuxibiologics.com |
IMU.AX | IMUGENE FPO | Sydney | Australia | AUD | ASX | 2.281 | -30.301 | https://www.imugene.com | |
600201.SS | JINYU BIO-TECHNOLOGY CO LTD | Hohhot | China | CNY | SHH | 0.307 | 18.759 | 1580 | https://www.jinyu.com.cn |
TMBR | Timber Pharmaceuticals, Inc. | Basking Ridge | United States | USD | ASE | 0.191 | 5 | https://www.timberpharma.com | |
300181.SZ | ZHEJIANG JOLLY PHA | Huzhou | China | CNY | SHZ | 0.095 | 18.504 | 2132 | https://www.zuoli.com |
CLVS | Clovis Oncology, Inc. | Boulder | United States | USD | NMS | 0.489 | -3.779 | 413 | https://www.clovisoncology.com |
ATHX | Athersys, Inc. | Cleveland | United States | USD | NCM | -1.304 | -0.603 | 104 | https://www.athersys.com |
VTGN | VistaGen Therapeutics, Inc. | South San Francisco | United States | USD | NCM | 1.065 | 0.746 | 36 | https://www.vistagen.com |
300009.SZ | ANHUI ANKE BIOTECH | Hefei | China | CNY | SHZ | 0.384 | 19.323 | https://www.ankebio.com | |
300122.SZ | CHONGQING ZHIFEI B | Chongqing | China | CNY | SHZ | 0.765 | 11.890 | 4800 | https://www.zhifeishengwu.com |
2370.T | MEDINET CO LTD | Tokyo | Japan | JPY | JPX | 1.344 | -2.690 | 92 | https://www.medinet-inc.co.jp |
2137.HK | BRII-B | Beijing | China | HKD | HKG | -5.411 | 113 | https://www.briibio.com | |
1530.HK | 3SBIO | Shenyang | China | HKD | HKG | 0.838 | 6.754 | 5292 | https://www.3sbio.com |
1801.HK | INNOVENT BIO | Suzhou | China | HKD | HKG | -0.306 | -14.035 | 5568 | https://www.innoventbio.com |
300497.SZ | JIANGXI FUSHINE PH | Jingdezhen | China | CNY | SHZ | 0.144 | 35.189 | 1849 | https://www.fushine.cn |
300147.SZ | XIANGXUE PHARMACEU | Guangzhou | China | CNY | SHZ | 0.592 | 374.628 | 3378 | https://www.xphcn.com |
BLUE | bluebird bio, Inc. | Cambridge | United States | USD | NMS | 1.381 | -0.352 | 518 | https://www.bluebirdbio.com |
300204.SZ | STAIDSON (BEIJING) | Beijing | China | CNY | SHZ | 0.162 | -27.059 | 873 | https://www.staidson.com |
AKBA | Akebia Therapeutics, Inc. | Cambridge | United States | USD | NGM | 1.471 | -0.158 | 426 | https://www.akebia.com |
1873.HK | VIVA BIOTECH | Shanghai | China | HKD | HKG | 0.952 | 15.936 | 2127 | https://www.vivabiotech.com.cn |
300363.SZ | PORTON PHARMA SOLU | Chongqing | China | CNY | SHZ | -0.358 | 30.901 | 4158 | https://www.porton.cn |
VLON | Vallon Pharmaceuticals Inc. | Philadelphia | United States | USD | NCM | -1.149 | -0.240 | 2 | https://www.vallon-pharma.com |
SRNE | Sorrento Therapeutics, Inc. | San Diego | United States | USD | NCM | 2.175 | -2.589 | 799 | https://www.sorrentotherapeutics.com |
NVAX | Novavax, Inc. | Gaithersburg | United States | USD | NMS | 1.579 | -2.578 | 1541 | https://www.novavax.com |
300759.SZ | PHARMARON BEIJING | Beijing | China | CNY | SHZ | 0.279 | 49.225 | 14923 | https://www.pharmaron.com |
300404.SZ | BOJI MEDICAL & TEC | Guangzhou | China | CNY | SHZ | -0.101 | 63.408 | 989 | https://www.bojicro.com |
RIGL | Rigel Pharmaceuticals, Inc. | South San Francisco | United States | USD | NMS | 1.664 | -2.332 | 165 | https://www.rigel.com |
688180.SS | SHANGHAI JUNSHI BIOSCIENCES CO | Shanghai | China | CNY | SHH | 0.242 | -39.918 | 2805 | https://www.junshipharma.com |
600161.SS | BEIJING TIANTAN BIOLOGICAL PROD | Beijing | China | CNY | SHH | 0.016 | 23.288 | 3933 | https://www.tiantanbio.com |
9939.HK | KINTOR PHARMA-B | Suzhou | China | HKD | HKG | -0.774 | -5.985 | 316 | https://www.kintor.com.cn |
VERU | Veru Inc. | Miami | United States | USD | NCM | -0.412 | -41.179 | 252 | https://www.verupharma.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.